Immune-related saliva micro-RNA’s to predict clinical response to a combination of cetuximab and low-dose chemotherapy in head and neck cancer (HNSCC) patients (pts) with poor performance status (PS).
In collaboration with IIT Delhi, AIIMS has developed a cost-effective prosthesis for patients with throat cancer who have lost their ability to speak. The prosthesis is placed through the ...
Voice Restoration Devices Market grows from $531.29 Million (2022) to $602.75 Million (2031) at 9.58% CAGR, driven by cancer cases & TEP demand. From $531.29 Million in 2022 to $602.75 Million by 2031 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback